ArticleIJID regions2025
Human parvovirus B19 infection in dengue patients and potential association with disease progression and clinical outcomes.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Parvoviruses at the Heart: Endothelial Injury and Myocyte Lysis in Human B19V and Canine CPV-2 Infections.Current issues in molecular biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Many viruses can present with clinical symptoms resembling dengue fever (DF), including human parvovirus B19 (B19V). Therefore, patients with DF are not often tested for secondary pathogens. The current study aimed to investigate B19V infection and its association with clinical features in dengue patients. Methods: A total of 230 subjects were recruited for this study, including patients with DF (n = 86), DF with warning signs (DWS, n = 53), and healthy controls (n = 91). Plasma samples were analyzed for B19V using enzyme-linked immunosorbent assay, nested polymerase chain reaction, sequencing, and phylogenetic analysis. The potential association between B19V infection and dengue progression was investigated. Results: Anti-B19V immunoglobulin M antibodies were detected across all groups: 17.4% in the DF group, 7.5% in the DWS group, and 13.2% in healthy controls. Anti-B19V immunoglobulin G positivity was most prevalent in DF patients (26.7%), followed by healthy controls (22.0%) and DWS patients (20.8%). B19V DNA was identified in 10 of 139 dengue patients (7.2%), but not in healthy controls. The rate of B19V infection was significantly higher in DWS patients than in those with DF, suggesting that B19V infection during dengue may be associated with an increased risk of a more severe form of disease (odds ratio = 4.4, Conclusions: This study reports the prevalence of B19V infection in Vietnamese dengue patients and reveals a potential association with dengue progression and clinical features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.